NCT05363488View on ClinicalTrials.gov

Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

October 8, 2021

Study Completion Date

October 8, 2021

Conditions
Myeloid Leukemia
Interventions
DRUG

Bosutinib

Patients receiving bosutinib treatment

Trial Locations (1)

Unknown

eatson West of Scotland Cancer Centre, Glasgow

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05363488 - Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland | Biotech Hunter | Biotech Hunter